logo
ENTITY

Shenzhen Neptunus Interlong Bio Tech Co (8329 HK)

1
Analysis
Health Care • China
Shenzhen Neptunus Interlong Bio-technique Co.Ltd. engages in the R&D, production, and sales and distribution of biological pharmaceuticals. The Company specializes in gene engineering drugs and preventive biological products.
more
Exchange Announcement • 10 Dec 2024 22:06

Documents On Display

Exchange Announcement • 10 Dec 2024 22:00

Form Of Proxy For The Extraordinary General Meeting

Exchange Announcement • 10 Dec 2024 21:58

Notice Of Extraordinary General Meeting

Exchange Announcement • 10 Dec 2024 21:56

(1) Revision Of Annual Cap And Early Termination In Relation To The 2023 Yidianyao Distribution Agreement; (2) Continuing Connected Transaction In Relation To The 2024 Yidianyao Distribution Agreement; (3) Continuing Connected Transaction In Relation To Renewal Of The 2021 Pharmaceutical Distribution Agreement; And (4) Notice Of Extraordinary General Meeting

Exchange Announcement • 15 Nov 2024 18:53

(1) Revision Of Annual Cap In Relation To The 2023 Yidianyao Distribution Agreement; (2) Termination Of The 2023 Yidianyao Distribution Agreement; (3) Continuing Connected Transaction In Relation To The 2024 Yidianyao Distribution Agreement; And (4) Continuing Connected Transaction In Relation To Renewal Of The 2021 Pharmaceutical Distribution Agreement

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x